Celebrating a 7-Year Collaboration with King’s College London

Celebrating a 7-Year Collaboration with King’s College London

We are excited to share the outcomes of our 7-year partnership with King’s College London, recently published in Frontiers in Pharmacology. This collaboration has focused on elevating the standards of Medicines Development education through our innovative blended e-learning and certification program.

A Global Impact

Our Certification in Medicines Development (CMD) Program has made significant strides in fostering a global community of Medicines Development professionals. Engaging 682 participants from 86 countries, we have successfully created a diverse and collaborative learning environment that transcends geographical boundaries.

Innovative Curriculum and High Satisfaction

The comprehensive curriculum, based on the PharmaTrain syllabus, combines asynchronous lectures and synchronous webinars. It has consistently received high satisfaction ratings, averaging over 4.0 on a five-point scale. The program’s structure, featuring 64 online lectures, 24 webinars, 25 discussion forums, and regular evaluations, ensures a rigorous and interactive educational experience with experts from academia, the pharmaceutical industry, CROs and regulatory institutions.

Enhancing Professional Competence and Career Growth

Our assessments, using Kirkpatrick’s model, have demonstrated the program’s effectiveness in enhancing professional competencies. Key highlights include:

  • High Satisfaction: Participants report elevated levels of satisfaction, with an overall mean response exceeding 4.0.
  • Significant Learning Gains: The program’s success rate averages 83%, reflecting substantial cognitive gains.
  • Positive Behavioral Changes: 70% of responding alumni have reported significant improvements in their job functions, supported by 30% of their supervisors.
  • Career Advancement: The program has facilitated notable career progression and professional development for many participants.

Key Study Findings

The study, published in Frontiers, provides a comprehensive analysis of the program’s impact:

  • Participant Feedback: Consistently high satisfaction and recommendation rates among participants.
  • Professional Growth: Significant gains in professional competencies and job performance including changes in behaviors and attitudes. 
  • Organizational Impact: Preliminary evidence suggests enhanced knowledge transfer and career progression, although further long-term impacts are still being established.

Strengthening the Profession Through Collaboration

Our partnership with King’s College London has been instrumental in ensuring the program’s academic rigor and relevance. The Center for Pharmaceutical Medicine Research at King’s College has provided invaluable expertise and support, facilitating continuous improvement and alignment with industry advancements.

Looking Ahead

Building on our success, we are expanding our educational offerings to include additional certifications and customized programs. Our goal is to continue supporting professionals in achieving excellence and driving innovation in Medicines Development.

Explore Our Findings

We invite you to delve into the detailed results of our study published in Frontiers in Pharmacology and join us in our mission to advance Medicines Development education. Together, we are shaping the future of Pharmaceutical Medicine/Medicines Development through continuous learning and collaboration.

🔗 Read the full study on Frontiers in Pharmacology

Stay connected for more updates and join the conversation with #MedDevRevolution #PharmaInnovation #BlendedLearning #GMDPAcademy #PublishedInFrontiers.

GMDP Academy is dedicated to advancing the field of Medicines Development through world-class education and training. Learn more about our programs and initiatives here.

References

  1. Silva, H., Stonier, P., Chopra, P., Coots, J., Criscuolo, D., Guptha, S., Jones, S., Kerpel-Fronius, S., Kesselring, G., Luria, X., Morgan, D., Power, E., Salek, S., Silva, G., Suto, T., Thakker, K., & Vandenbroucke, P. (2024). Blended e-learning and certification for medicines development professionals: results of a 7-year collaboration between King’s College, London and the GMDP Academy, New York. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1417036

Disclaimers

  • The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
  • Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
  • No official support by any organization(s) has been provided or should be inferred